论文部分内容阅读
目的:探讨痰热清治疗手足口病(HFMD)的临床价值。方法:110例HFMD患儿,随机分为对照组50例,治疗组60例。两组常规抗病毒、支持等治疗基础上,治疗组加用痰热清0.5ml/kg+5%葡萄糖注射液100ml,日一次静点,疗程7d。观察指标:记录两组病例的发热、和普通型向重型转化趋势。结果:观察结束后,两组退热时间为(3.72±1.02)d和(2.25±0.97)d(P<0.05),皮疹消退时间(6.70±1.88)d和(5.21±1.82)d(P<0.01);两组由普通型进展为重型分别为17.8%和3.8%(P<0.05)。结论:痰热清治疗HFMD具有一定疗效。
Objective: To investigate the clinical value of Tanreqing in treating hand-foot-mouth disease (HFMD). Methods: A total of 110 children with HFMD were randomly divided into control group (50 cases) and treatment group (60 cases). Two groups of conventional anti-virus, support and other treatment based on the treatment group plus Tanreqing 0.5ml / kg + 5% glucose injection 100ml, once a static point, treatment 7d. OUTCOME MEASURES: The fever in both groups was recorded, along with the trend towards common type to heavy type. Results: After the observation, the antipyretic time of the two groups were (3.72 ± 1.02) d and (2.25 ± 0.97) days (P <0.05), and the rash subsided time was 6.70 ± 1.88 days and 5.21 ± 1.82 days respectively 0.01). The two groups were 17.8% and 3.8% respectively (P <0.05). Conclusion: Tanreqing treatment of HFMD has a certain effect.